789
Views
14
CrossRef citations to date
0
Altmetric
Clinical Research

Current fatality rate of suspected cyclopeptide mushroom poisoning in the United States

, , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 24-27 | Received 20 Jan 2020, Accepted 19 Mar 2020, Published online: 02 Apr 2020

References

  • Nguyen VT, Giannoni F, Dubois MF, et al. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res. 1996;24(15):2924–2929.
  • Enjalbert F, Rapior S, Nouguier-Soule J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715–757.
  • Floersheim GL, Weber O, Tschumi P, et al. Clinical death-cap (Amanita phalloides) poisoning: prognostic factors and therapeutic measures. Analysis of 205 cases. Schweiz Med Wochenschr. 1982;112:1164–1177.
  • Jander S, Bischoff J, Woodcock BG. Plasmapheresis in the treatment of amanita phalloides poisoning: II. A review and recommendations. Ther Apher. 2000;4(4):308–312.
  • De Olano J, Wang J, Biary R, et al. Modern lethality rate of suspected cyclopeptide mushroom poisoning in the US: the power of supportive care! [abstract]. Clinical Toxicology. 2019;57:875.
  • Mengs U, Pohl RT, Mitchell T. Legalon(R) SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. CPB. 2012;13(10):1964–1970.
  • Gummin DD, Mowry JB, Spyker DA, et al. 2018 annual report of the american association of poison control centers’ National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila). 2019;57(12):1220–1413.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.